Invion IVIXF Stock
Invion Price Chart
Invion IVIXF Financial and Trading Overview
| Invion stock price | 0.04 USD |
| Previous Close | 0.04 USD |
| Open | 0.0018 USD |
| Bid | 0.01 USD x 3000000 |
| Ask | 0.07 USD x 2000000 |
| Day's Range | 0.0018 - 0.0018 USD |
| 52 Week Range | 0.0018 - 0.04 USD |
| Volume | 2 USD |
| Avg. Volume | 0 USD |
| Market Cap | 4.03M USD |
| Beta (5Y Monthly) | 0.423 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IVIXF Valuation Measures
| Enterprise Value | 4.98M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.474213 |
| Price/Book (mrq) | 0.91964906 |
| Enterprise Value/Revenue | 12.957 |
| Enterprise Value/EBITDA | -1.265 |
Trading Information
Invion Stock Price History
| Beta (5Y Monthly) | 0.423 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0018 USD |
| 50-Day Moving Average | 0.04 USD |
| 200-Day Moving Average | 0.04 USD |
IVIXF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 109.2M |
| Float | 64.65M |
| Short Ratio | N/A |
| % Held by Insiders | 46.66% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -567.068% |
| Gross Margin | -285.44% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.097% |
| Return on Equity (ttm) | -83.016% |
Income Statement
| Revenue (ttm) | 384.71K USD |
| Revenue Per Share (ttm) | 0.004 USD |
| Quarterly Revenue Growth (yoy) | 12675.89% |
| Gross Profit (ttm) | -1098135 USD |
| EBITDA | -3941460 USD |
| Net Income Avi to Common (ttm) | -5632977 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 592.31K USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 1.55M USD |
| Total Debt/Equity (mrq) | 29.09 USD |
| Current Ratio (mrq) | 0.245 |
| Book Value Per Share (mrq) | 0.040124 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2373541 USD |
| Levered Free Cash Flow (ttm) | -1865101 USD |
Profile of Invion
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | 385 Bourke Street |
| ZIP | 3000 |
| Phone | 61 3 9692 7222 |
| Website | https://www.inviongroup.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in South Korea. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme (GBM), lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Q&A For Invion Stock
What is a current IVIXF stock price?
Invion IVIXF stock price today per share is 0.04 USD.
How to purchase Invion stock?
You can buy IVIXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Invion?
The stock symbol or ticker of Invion is IVIXF.
Which industry does the Invion company belong to?
The Invion industry is Drug Manufacturers - Specialty & Generic.
How many shares does Invion have in circulation?
The max supply of Invion shares is 109.2M.
What is Invion Price to Earnings Ratio (PE Ratio)?
Invion PE Ratio is now.
What was Invion earnings per share over the trailing 12 months (TTM)?
Invion EPS is -0.07 USD over the trailing 12 months.
Which sector does the Invion company belong to?
The Invion sector is Healthcare.
